Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Tyrosine Phosphatases | 1 | 2023 | 4 | 0.770 |
Why?
|
| Bone Development | 1 | 2023 | 20 | 0.760 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2019 | 58 | 0.640 |
Why?
|
| Nanotubes | 3 | 2025 | 12 | 0.640 |
Why?
|
| Aggrecans | 2 | 2019 | 14 | 0.630 |
Why?
|
| Arthritis, Experimental | 2 | 2019 | 26 | 0.620 |
Why?
|
| Citrulline | 2 | 2019 | 3 | 0.530 |
Why?
|
| Epitopes | 1 | 2016 | 9 | 0.490 |
Why?
|
| Proteoglycans | 1 | 2016 | 32 | 0.490 |
Why?
|
| Anti-Bacterial Agents | 3 | 2025 | 109 | 0.450 |
Why?
|
| Prosthesis-Related Infections | 2 | 2024 | 46 | 0.400 |
Why?
|
| Animals | 6 | 2025 | 1349 | 0.390 |
Why?
|
| Mice | 4 | 2025 | 465 | 0.360 |
Why?
|
| Gentamicins | 3 | 2025 | 13 | 0.320 |
Why?
|
| Chitosan | 3 | 2025 | 12 | 0.310 |
Why?
|
| Titanium | 2 | 2025 | 64 | 0.270 |
Why?
|
| Osseointegration | 1 | 2025 | 46 | 0.220 |
Why?
|
| Prostheses and Implants | 1 | 2025 | 71 | 0.220 |
Why?
|
| Joint Prosthesis | 1 | 2024 | 21 | 0.210 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 30 | 0.210 |
Why?
|
| Research Design | 1 | 2024 | 42 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2023 | 3 | 0.190 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 53 | 0.190 |
Why?
|
| X-Ray Microtomography | 1 | 2023 | 65 | 0.190 |
Why?
|
| Flow Cytometry | 2 | 2019 | 32 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2019 | 17 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2019 | 136 | 0.160 |
Why?
|
| Azacitidine | 1 | 2019 | 7 | 0.150 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2019 | 1 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 51 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 26 | 0.140 |
Why?
|
| Male | 2 | 2024 | 3399 | 0.140 |
Why?
|
| DNA Methylation | 1 | 2019 | 72 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 22 | 0.120 |
Why?
|
| Spleen | 1 | 2016 | 7 | 0.120 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 46 | 0.120 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 24 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2016 | 43 | 0.120 |
Why?
|
| Cytokines | 1 | 2016 | 63 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2016 | 167 | 0.120 |
Why?
|
| Humans | 4 | 2024 | 5837 | 0.120 |
Why?
|
| Staphylococcus aureus | 2 | 2025 | 17 | 0.110 |
Why?
|
| Female | 1 | 2023 | 3346 | 0.110 |
Why?
|
| Alloys | 1 | 2025 | 25 | 0.060 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2025 | 17 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 122 | 0.060 |
Why?
|
| Electroplating | 1 | 2024 | 3 | 0.060 |
Why?
|
| Consensus | 1 | 2024 | 21 | 0.050 |
Why?
|
| Models, Animal | 1 | 2024 | 62 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2024 | 601 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2019 | 11 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 11 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 12 | 0.040 |
Why?
|
| HLA-DRB1 Chains | 1 | 2019 | 1 | 0.040 |
Why?
|
| Autoantigens | 1 | 2019 | 4 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2019 | 11 | 0.040 |
Why?
|
| Registries | 1 | 2019 | 45 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 222 | 0.030 |
Why?
|